"Inlita" (axitinib): analogues, price. Where to buy more cheaply

A drug called "Inlita" refers to a group of protein kinase inhibitors. It is prescribed as second-line therapy for advanced renal cell carcinoma.

The drug "Inlita" reviews doctors and patients gets good. Both of them call the drug highly effective, actually working and slowing the growth of tumors. The only drawback of the drug "Inlita" - the price. It's really high enough. So, packing of tablets in a dosage of 1 mg in Moscow is sold at a price of 160,000 rubles, 5 mg - 190,000 rubles. However, the drug can be found at a lower cost.

What are generics?

Generics are drugs that have a pharmacological formula the same as the original means. But they are much cheaper. The difference can be overwhelming. So what's the secret?

The secret is that the generic producer does not spend money on the development of an effective formula, on clinical trials, advertising. This allows you to significantly reduce the cost of the drug. This also applies to the drug "Inlita". The price of a generic is several times lower, and such a drug becomes available to a wider range of patients.

How to buy the drug "Inlita" cheaper

To purchase the generic medicinal product under consideration, contact the WWW.ONKO24.COM Internet resource . Here you can find other antitumor drugs.

Sending of the ordered items is carried out from India. Specialists of the company with five years of experience will answer all your questions. Remember that the order on the site can be carried out by people who have documents confirming the need to use a particular medicine.

"Inlita": the instruction to the preparation

The drug is taken twice a day. The recommended initial dose is 5 mg. Correction of it should be made by the attending physician.

The tablet should be swallowed without chewing and drinking a whole glass of water. The drug is consumed regardless of previous meals. It is desirable that the interval between taking two tablets is 12 hours.

What side effects can develop

The instructions for use with the preparation "Inlita" warn of the toxicity of the drug. During therapy, the following adverse reactions may develop:

• Increased blood pressure;
• Bleeding;
• Arterial thromboembolism;
• diarrhea;
• nausea and vomiting;
• stomach ache;
• Hypothyroidism;
• Headache and dizziness;
• anemia;
• arthralgia;
• Palmar-plantar syndrome;
• Itching and skin rash.

Contraindications

"Inlita" has a rather impressive list of contraindications. The drug is prohibited in the following cases:

• Individual intolerance to axitinib, the main active substance of the drug;
• Venous and arterial thromboembolism;
• Impaired liver function;
• Gastrointestinal bleeding;
• Metastases in the brain;
• Pregnancy and lactation;
• Age to 18 years.

Treatment with the drug "Inlita" should be carried out exclusively under the supervision of an experienced oncologist.